Literature DB >> 8823529

Effect of phosphate on the parathyroid gland: direct and indirect?

M Rodriguez1, Y Almaden, A Hernandez, A Torres.   

Abstract

Hyperparathyroidism is a common finding in patients with renal failure. Phosphorus retention is known to be an important factor in the development of secondary hyperparathyroidism. Exciting new work has demonstrated that a high extracellular phosphorus concentration directly stimulates parathyroid hormone secretion and synthesis. Dietary phosphorus also modulates parathyroid function indirectly by decreasing calcitriol production, and it interferes with the calcaemic response to parathyroid hormone. The information available suggests that the control exerted by phosphorus is critical, via indirect and direct actions, in preventing the development of secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823529     DOI: 10.1097/00041552-199607000-00006

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  4 in total

1.  Characterization of mandibular bone in a mouse model of chronic kidney disease.

Authors:  Melissa M Lee; Emily Y Chu; Mohga M El-Abbadi; Brian L Foster; Kevin A Tompkins; Cecilia M Giachelli; Martha J Somerman
Journal:  J Periodontol       Date:  2010-02       Impact factor: 6.993

Review 2.  Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.

Authors:  Víctor Lorenzo Sellares; Armando Torres Ramírez
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 3.  Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

Authors:  A Galassi; A Cupisti; A Santoro; M Cozzolino
Journal:  J Nephrol       Date:  2014-09-23       Impact factor: 3.902

Review 4.  Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly.

Authors:  Andrea Galassi; Paola Ciceri; Eliana Fasulo; Stefano Carugo; Giuseppe Cianciolo; Mario Cozzolino
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.